CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | ||||
| Net Sales | $ 4,808,812 | $ 9,056,742 | $ 22,672,212 | $ 28,505,928 |
| Cost of Goods Sold | 4,166,954 | 4,899,247 | 23,085,201 | 18,884,646 |
| Gross Profit | 641,858 | 4,157,495 | (412,989) | 9,621,282 |
| Operating Expenses | ||||
| Payroll Expense | 1,070,534 | 1,169,117 | 3,481,434 | 3,665,391 |
| Professional Fees | 137,817 | 132,424 | 354,431 | 568,108 |
| Bank Charges and Merchant Fees | 134,025 | 159,042 | 423,594 | 441,908 |
| Advertising and Marketing | 578,284 | 426,573 | 1,410,455 | 1,374,018 |
| Provision for Credit Losses - Settlement Receivables | 25,000 | 0 | 25,000 | 0 |
| Bad Debt Expense | 864,376 | 418,918 | 863,753 | 664,686 |
| Impairment of Hemp-Specific Fixed Assets | 0 | 0 | 208,049 | 0 |
| Depreciation and Amortization | 22,299 | 62,161 | 132,236 | 186,938 |
| Collab Commission and Royalty Expense | 0 | 33,899 | 0 | 106,739 |
| Other Operating Expenses | 443,363 | 442,570 | 1,414,315 | 1,738,729 |
| Total Operating Expenses | 3,275,698 | 2,844,704 | 8,313,267 | 8,746,517 |
| Income/(Loss) From Operations | (2,633,840) | 1,312,791 | (8,726,256) | 874,765 |
| Other Income/(Expenses) | ||||
| Impairment of Investment in Bendistillery | 0 | 0 | (99,800) | 0 |
| Interest Income | 6,930 | 23,695 | 22,794 | 75,677 |
| Interest Expense | (20,837) | (73,481) | (63,813) | (230,948) |
| Loss From Inventory Theft | 0 | (358,072) | 0 | (358,072) |
| Theft Expense | 0 | 0 | 0 | (350,000) |
| Settlement Income | 0 | 0 | 0 | 177,500 |
| Settlement Costs | 0 | 0 | (100,000) | 0 |
| Debt Financing Expenses | (799) | (32,803) | (25,790) | (38,318) |
| Loss on Debt Extinguishment | (16,209) | 0 | (16,209) | 0 |
| Penalties | (1,023) | (1,316) | (4,627) | (2,999) |
| Gain/(Loss) on Disposal of Assets Held for Sale and Other Fixed Assets | 143,468 | 0 | 131,342 | 0 |
| Loss on Deposits | 0 | 0 | 0 | (5,000) |
| Gain on Forgiveness of Debt | 0 | 0 | 0 | 21,681 |
| Total Other Income/(Expenses) | 111,530 | (441,977) | (156,103) | (710,479) |
| Income/(Loss) Before Provision for Income Taxes | (2,522,310) | 870,814 | (8,882,359) | 164,286 |
| Benefit/(Provision) for Income Taxes | (817,139) | (236,557) | (55,329) | (102,021) |
| Net Income/(Loss) | (3,339,449) | 634,257 | (8,937,688) | 62,265 |
| Less: Accrued Preferred Stock Dividends | (3,403) | (3,403) | (10,097) | (10,099) |
| Net Income/(Loss) Attributable to Common Stockholders | $ (3,342,852) | $ 630,854 | $ (8,947,785) | $ 52,166 |
| Earnings/(Loss) Per Common Share Attributable to Common Stockholders | ||||
| Basic | $ (0.23) | $ 0.04 | $ (0.60) | $ 0.00 |
| Diluted | $ (0.23) | $ 0.04 | $ (0.60) | $ 0.00 |
| Weighted average number of common shares outstanding | ||||
| Basic | 14,822,678 | 14,822,678 | 14,822,678 | 14,822,678 |
| Diluted | 14,822,678 | 14,964,678 | 14,822,678 | 14,964,678 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This element represents interest incurred for borrowed money which was used to produce goods or render services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of estimated penalties recognized in the period arising from income tax examinations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense related to credit loss from transactions other than loan and lease transactions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|